Directorate Change and Appointment of New Chairman

RNS Number : 2100B
Maven Income and Growth VCT 5 PLC
28 January 2020
 

 

 

 

 

Maven Income and Growth VCT 5 PLC (the Company)

 

Directorate Change and Appointment of New Chairman

 

As announced in the Company's 2018 Annual Report and in the 2019 Interim Report, Allister Langlands will step down as Chairman and from the Board following the conclusion of the Company's Annual General Meeting (AGM) to be held on 28 April 2020.

 

Graham Miller was appointed to the Board as a Non-executive Director on 2 July 2019 and a resolution for Shareholders to confirm his election will be proposed at the 2020 AGM. Since his appointment, Mr Miller has proved to be a valuable member of the Board.

 

The Board, in considering a successor to Mr Langlands as Chairman, have agreed that Mr Miller is the most suitable candidate for the role. Accordingly, Mr Miller will assume the role of Chairman following the conclusion of the 2020 AGM.

 

Mr Miller began his business career with Murray Johnstone Private Equity in 1987, becoming a Director in 1994. He was Corporate Development Director of Avon Rubber PLC from 1998 to 2001 before returning to private equity with 3i plc. Since 2008, he has operated as an Independent Director and private investor.

 

Mr Miller currently chairs Westfield Medical Limited (a medical packaging MBO) and Shiner Limited (a family owned action sports distributor).  He is a Non-executive Director of AIM listed Sutton Harbour Group PLC where he also chairs the Audit Committee and a Non-executive Director of Fidelius Financial Holdings Limited, a privately owned wealth management group.

 

The Board would like to thank Mr Langlands for his hard work and commitment to the role of Director and Chairman since his appointment on 1 June 2013 and wish him every success in his retirement.

 

 

Maven Capital Partners UK LLP

Company Secretary

 

28 January 2020

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADZGZMVRLGGZM
UK 100